<DOC>
	<DOC>NCT00937859</DOC>
	<brief_summary>The purpose of this study is to evaluate a treatment of nocturia. The hypothesis is that SER120 will decrease the number of nocturic episodes compared to placebo.</brief_summary>
	<brief_title>Treatment of Patients With Nocturia</brief_title>
	<detailed_description />
	<mesh_term>Nocturia</mesh_term>
	<criteria>Male and female 50 years or older Nocturia of 6 or more months duration averaging 2 episodes or more per night CHF Diabetes Diabetes Insipidus Renal Insufficiency Hepatic Insufficiency Incontinence Illness requiring steroids Current or past urologic malignancy Nephrotic Syndrome Unexplained pelvic masses Urinary bladder neurological dysfunction Urinary bladder surgery or radiotherapy Sleep Apnea Pregnant or breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>